Internal Medicine NewsType 3 von Willebrand a rare but serious bleeding disorderMarch 10, 2021Hematology
Internal Medicine NewsBleeding disorder diagnoses delayed by years in girls and womenMarch 9, 2021Mixed TopicsHematology
Internal Medicine News‘Phenomenal’ results with CAR T cells in R/R multiple myelomaMarch 4, 2021HematologyOncology
Internal Medicine NewsNew ASH guidelines: VTE prevention and treatment in cancer patientsMarch 2, 2021Preventive CareHematologyOncology
Internal Medicine NewsSteroid complications in GVHD common, boost costs of careFebruary 19, 2021Hematology
Internal Medicine NewsFactor VIII concentrate is here to stay in hemophilia AFebruary 9, 2021Hematology
Internal Medicine NewsCLL, MBL had lower response rates to flu vaccination, compared with healthy adultsFebruary 9, 2021VaccinesHematologyInfectious Diseases
Internal Medicine NewsFDA okays new CAR T-cell treatment for large B-cell lymphomasFebruary 8, 2021Hematology
Internal Medicine NewsImmunoabsorption shows promise as an adjunct treatment for high-risk acquired hemophiliaFebruary 3, 2021Hematology
Internal Medicine NewsFull-dose anticoagulation reduces need for life support in COVID-19January 25, 2021COVID-19 UpdatesCardiologyHematology
Internal Medicine NewsVon Willebrand disease guidelines address women’s bleeding concernsJanuary 19, 2021Hematology
Internal Medicine NewsConcern over response to COVID-19 in patients with blood cancersJanuary 12, 2021COVID-19 UpdatesHematologyOncology
Internal Medicine NewsIn COVID-19 patients, risk of bleeding rivals risk of thromboembolismJanuary 12, 2021CardiologyCOVID-19 UpdatesHematology
Internal Medicine NewsA 4-point thrombocytopenia score was found able to rule out suspected HITJanuary 11, 2021HematologyPreventive Care
